Product information
Luminoma Diagnostics - Summary
Skin cancer screening involves assessing a mole’s appearance. Diagnosing skin cancers can be challenging and primarily relies on a clinician's judgement and expertise. Experienced clinician’s will miss 1 in 8 cancers whilst less experienced clinicians can miss up to half. So to avoid missing a cancer, clinicians can make as many as 10 specialist referrals for every cancer found. This results in unnecessary biopsies that not only waste time and money but can cause unsightly scarring.
Luminoma is developing the LumAssure, a non-invasive, point-and-click device that indicates whether a skin lesion is malignant or benign within seconds. The LumAssure will reduce missed cancers from 1 in 8 to less than 1 in 100 as well as reducing unnecessary biopsies by three quarters. The diagnostic-aid’s high accuracy provides clinicians with assurance in their biopsy decisions without having to wait days for a lab result. We will first launch with premium dermatology clinics whose patients will want the convenience of an instant result whilst avoiding unnecessary procedures and scarring. We estimate the market in the US to be a US$2B annual recurring revenue opportunity.
See our offer documentation under the Key documents tab above for more information.
Capital raise
Luminoma is now raising $2.6M to fund clinical studies at the Mayo Clinic, UC San Francisco and the University of Queensland, Australia at a pre-money valuation of NZ$11M.
- This Capital raise is being led by Pacific Channel VC
- $900,000 target for NZ Clinical study closed
- Rolling close for additional $2.6M to fund clinical studies in Brisbane and the US
- Pre-money valuation - NZ$11M
US$2 Bil ARR Opportunity
- $211 per patient x 1350* patients per year = $284,850 per dermatologist per year x 7000 US dermatologists = US$2 Billion ARR Serviceable Obtainable Market
*6 uses per day. Clinics with a lot of fair skinned retires such as Veteran Affair Hospitals and the Florida villages have said that, with reimbursement, it would be used on “almost all” of their 50+ patients per day.
Click on the Key documents tab above to learn more
Additional information, including a business plan, is available by contacting us. Also contact us with any questions.
Click on the "Invest" button to submit your investment commitment.
This offer is open to Wholesale investors only.
